---
title: Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver
  disease
date: '2024-01-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38216754/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240113170711&v=2.18.0
source: heidelberg[Affiliation]
description: Chronic liver diseases are worldwide on the rise. Due to the rapidly
  increasing incidence, in particular in Western countries, metabolic dysfunction-associated
  steatotic liver disease (MASLD) is gaining importance as the disease can develop
  into hepatocellular carcinoma. Lipid accumulation in hepatocytes has been identified
  as the characteristic structural change in MASLD development, but molecular mechanisms
  responsible for disease progression remained unresolved. Here, we uncover in ...
disable_comments: true
---
Chronic liver diseases are worldwide on the rise. Due to the rapidly increasing incidence, in particular in Western countries, metabolic dysfunction-associated steatotic liver disease (MASLD) is gaining importance as the disease can develop into hepatocellular carcinoma. Lipid accumulation in hepatocytes has been identified as the characteristic structural change in MASLD development, but molecular mechanisms responsible for disease progression remained unresolved. Here, we uncover in ...